0001192482-15-000120.txt : 20150423
0001192482-15-000120.hdr.sgml : 20150423
20150423145410
ACCESSION NUMBER: 0001192482-15-000120
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20150423
DATE AS OF CHANGE: 20150423
EFFECTIVENESS DATE: 20150423
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-238568
FILM NUMBER: 15788188
BUSINESS ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: (484) 395-2400
MAIL ADDRESS:
STREET 1: 490 LAPP ROAD
CITY: MALVERN
STATE: PA
ZIP: 19355
D
1
primary_doc.xml
X0707
D
LIVE
0001588972
Recro Pharma, Inc.
490 LAPP ROAD
MALVERN
PA
PENNSYLVANIA
19355
(484) 395-2400
PENNSYLVANIA
None
None
Corporation
true
Gerri
A.
Henwood
c/o Recro Pharma, Inc.
490 Lapp Road
Malvern
PA
PENNSYLVANIA
19355
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2015-04-10
false
true
true
Warrants were issued in connection with the Company's purchase of certain subsidiaries of Alkermes plc pursuant to a Purchase and Sale Agreement. See the Company's Form 8-K filed on April 15, 2015.
0
7778364
7778364
0
false
2
0
0
0
false
Recro Pharma, Inc.
/s/ Gerri A. Henwood
Gerri A. Henwood
President & CEO
2015-04-23